Member Info for doze

So my shares should appear on my TD account then?hopefully.

Almonty could do a behind the scenes provisional deal with Oaktree and because they have other operations in the region they could therefore afford to be more generous to Oaktree. Almonty are better placed to be operator so will deliver better profits to Oaktree ultimately. The question is what p/share are they prepared to pay. They will let the world know when they know how much of the project Oaktree want in exchange for the funding. Say the shares with internal funding are worth 10p, if Oaktree want 60% then say the shares are worth 4p so Almonty will need to offer 4p+

The fund targets UK investors who at the moment are supporting the strong dollar(or have been of late)so i assume they have been switching to US investments. In addition the emerging markets in which the fund is invested have more expensive costs when sourced in dollars. Their currency may have suffered against the strong pound too leading to currency losses reflected in the capital value. Having said all that, the reasons we are invested are still there and I don't see why they won't assert themselves in the long run.

A good analysis of Almonty/Oaktree dilemma granto. Oaktree will have to play softball to counter Almonty coming up behind.

The strong dollar is hurting this.

I was agreeing with your post. I wouldn't mind having Almonty shares instead of cash.

It is the majority of the project, not the company, Oaktree are getting. In the current state of mining companies the gist of your post does apply.

granto makes some good calcs but ORM options have been made difficult due to market conditions. A point I would make is the TSX has it over AIM and Irish Stock Exchange hence the Oaktree proposition and Almonty better able to get finance. 5p is a sensible offer but might not be successful and they might have to come back with a better one.

Despite what spindok says, Almonty is obviously using the Oaktree proposal to rekindle its bid and offer shareholders a quick return on the present price which will not match their former bid. 5p is a sensible prediction.

What cashback money do you receive?

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/12271191.html This is a notifying of the operation, lets hope it is successful. Not as big a deal as dermapure http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/11747339.html Which I hope is gaining traction in the US http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/12139754.html

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/12270611.html Excellent new market, small but a good recommendation by Bassama

I note however, there has been a steady rise since 24/2

Sorry, this came out on 24/2, Hargreaves Lansdowne sent me an email about it today.

Neil Woodford's new vehicle's prospectus cites his team's investment in Xeros as an example of investment strategy along with four other examples and this probably accounts for today's rise.

Hhardon's warnings have been gratefully received, if my recent posts have been ramps I apologize, was merely communicating with other posters.

Shaping up quite nicely and remember they don't share profits with any major pharma, Vamousse is their own product.

Thanks for your positive view on affairs. AAZ does seem a stable entity just waiting for all the variables to turn in favourable figures.

I am a fan of hers. I lost £5k with my last foray into AAZ but I now have a punt of almost double the number of shares for 20% the cost.

I am on it but haven't posted yet, surprise! How can we get Cousin Elmer to enthuse the US?